Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
ADIAL PHARMACEUTICALS, INC.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
ADIAL PHARMACEUTICALS, INC.Listing on record | BuyD (derivative) | $100K | SEC | ||
Rapport Therapeutics, Inc.Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Rapport Therapeutics, Inc.Listing unverified | Buy | $79.1K | conv 60 | SEC | |
Rapport Therapeutics, Inc.Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Rapport Therapeutics, Inc.Listing unverified | Buy | $61.3K | conv 74First in 12mo | SEC | |
Rapport Therapeutics, Inc.Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |